Hep C Drug Deal Raises Patient-Choice Concerns

A deal between Express Scripts, the nation’s largest pharmacy-benefits manager, and AbbVie, a big drug maker, over a new hepatitis C treatment is generating concern about the implications for patient choice.



from WSJ.com: US Business http://ift.tt/14vKW3B

via IFTTT